Figure 2From: Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXDisease-free survival by p53 expression (≥ 10%) at 12-year median follow-up. (A) All analysed patients. (B) Patients whose tumors expressed estrogen receptor (ER). (C) Patients whose tumors did not express ER.Back to article page